CCCC
C4 Therapeutics Inc
3.30$
+6.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -70.5% | -6.8% | +295.1% | +28.0% | -66.3% | +39.8% | -10.7% | +73.8% | -1.9% | -44.2% | +7.9% | – | |
| – | -15.2% | +19.9% | +0.9% | +0.5% | -14.1% | +14.0% | +3.5% | – | – | -0.3% | – | – | |
| – | -82.7% | +93.6% | +227.8% | +33.6% | -74.4% | +112.2% | -10.7% | +73.8% | -1.9% | -60.5% | +52.6% | – | |
| – | +7.2% | -25.9% | +5.4% | +34.0% | +2.1% | -16.7% | -3.2% | -0.8% | -3.9% | -1.5% | -0.5% | – | |
| – | -2.2% | -0.1% | -5.8% | +21.4% | -11.9% | -10.1% | -6.0% | +1.7% | +2.9% | +1.7% | -7.9% | – | |
| – | +5.7% | -9.6% | -10.9% | +32.3% | -1.0% | -11.5% | -4.0% | +30.5% | -25.2% | -5.9% | +2.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,344.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -72.4% | -831.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.